Free Access
Neurotrophic and neuroprotective effects of the neuregulin glial growth factor‐2 on dopaminergic neurons in rat primary midbrain cultures
Address correspondence and reprint requests to Kim B. Seroogy, PhD at his present address of Department of Neurology, University of Cincinnati College of Medicine, Vontz Center for Molecular Studies, Rm 2320, 3125 Eden Avenue, Cincinnati, OH 45267–0536, USA.
E‐mail: kim.seroogy@uc.edu
Abstract
Glial growth factor‐2 (GGF2) and other neuregulin (NRG) isoforms have been shown to play important roles in survival, migration, and differentiation of certain neural and non‐neural cells. Because midbrain dopamine (DA) cells express the NRG receptor, ErbB4, the present study examined the potential neurotrophic and/or neuroprotective effects of GGF2 on cultured primary dopaminergic neurons. Embryonic day 14 rat mesencephalic cell cultures were maintained in serum‐free medium and treated with GGF2 or vehicle. The number of tyrosine hydroxylase‐positive (TH+) neurons and high‐affinity [3H]DA uptake were assessed at day in vitro (DIV) 9. Separate midbrain cultures were treated with 100 ng/mL GGF2 on DIV 0 and exposed to the catecholamine‐specific neurotoxin 6‐hydroxydopamine (6‐OHDA) on DIV 4. GGF2 treatment significantly increased DA uptake, the number of TH+ neurons, and neurite outgrowth when compared to the controls in both the serum‐free and the 6‐OHDA‐challenged cultures. Furthermore, three NRG receptors were detected in the midbrain cultures by western blot analysis. Immunostaining for glial fibrillary acidic protein revealed that GGF2 also weakly promoted mesencephalic glial proliferation in the midbrain cultures. These results indicate that GGF2 is neurotrophic and neuroprotective for developing dopaminergic neurons and suggest a role for NRGs in repair of the damaged nigrostriatal system that occurs in Parkinson's disease.
Citing Literature
Number of times cited: 33
- Laura A. Struzyna, Kevin D. Browne, Zachary D. Brodnik, Justin C. Burrell, James P. Harris, H. Isaac Chen, John A. Wolf, Kate V. Panzer, James Lim, John E. Duda, Rodrigo A. España and D. Kacy Cullen, Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease, Journal of Tissue Engineering and Regenerative Medicine, 12, 7, (1702-1716), (2018).
- Zhihong Huang, Douglas B. Sawyer, Erika L. Troy, Corissa McEwen, John H. Cleator, Abigail Murphy, Anthony O. Caggiano, Andrew Eisen and Tom J. Parry, Species-specific effects of neuregulin-1β (cimaglermin alfa) on glucose handling in animal models and humans with heart failure, Toxicology and Applied Pharmacology, 10.1016/j.taap.2017.08.001, 332, (92-99), (2017).
- Tai‐Kyoung Baik, Young‐Jung Kim, Se‐Mi Kang, Dae‐Yong Song, Sun Seek Min and Ran‐Sook Woo, Blocking the phosphatidylinositol 3‐kinase pathway inhibits neuregulin‐1‐mediated rescue of neurotoxicity induced by Aβ1–42, Journal of Pharmacy and Pharmacology, 68, 8, (1021-1029), (2016).
- Rodolphe Hajj, Aude Milet, Damien Toulorge, Nathalie Cholet, Julien Laffaire, Julie Foucquier, Sandra Robelet, Richard Mitry, Mickael Guedj, Serguei Nabirotchkin, Ilya Chumakov and Daniel Cohen, Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson’s disease, Scientific Reports, 5, 1, (2015).
- Yuka Hama, Ichiro Yabe, Koichi Wakabayashi, Takahiro Kano, Makoto Hirotani, Yuriko Iwakura, Jun Utsumi and Hidenao Sasaki, Level of plasma neuregulin-1 SMDF is reduced in patients with idiopathic Parkinson’s disease, Neuroscience Letters, 587, (17), (2015).
- A.N. Koppes and D.M. Thompson, Neural innervation of engineered musculoskeletal tissues, Regenerative Engineering of Musculoskeletal Tissues and Interfaces, 10.1016/B978-1-78242-301-0.00012-4, (293-323), (2015).
- A Ledonne, A Nobili, E C Latagliata, V Cavallucci, E Guatteo, S Puglisi-Allegra, M D'Amelio and N B Mercuri, Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons, Molecular Psychiatry, 20, 8, (959), (2015).
- Hiroyuki Nawa, Hidekazu Sotoyama, Yuriko Iwakura, Nobuyuki Takei and Hisaaki Namba, Neuropathologic Implication of Peripheral Neuregulin-1 and EGF Signals in Dopaminergic Dysfunction and Behavioral Deficits Relevant to Schizophrenia: Their Target Cells and Time Window, BioMed Research International, 2014, (1), (2014).
- Weigang Cui, Jing Tao, Zhongping Wang, Mingxin Ren, Yinghua Zhang, Yan Sun, Yuwen Peng and Ruixi Li, Neuregulin1beta1 Antagonizes Apoptosis Via ErbB4-Dependent Activation of PI3-Kinase/Akt in APP/PS1 Transgenic Mice, Neurochemical Research, 38, 11, (2237), (2013).
- C A Bousman, A R Yung, C Pantelis, J A Ellis, R A Chavez, B Nelson, A Lin, S J Wood, G P Amminger, D Velakoulis, P D McGorry, I P Everall and D L Foley, Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis, Translational Psychiatry, 3, 4, (e251), (2013).
- Jin-Jing Yao, Ji Sun, Qian-Ru Zhao, Chang-Ying Wang and Yan-Ai Mei, Neuregulin-1/ErbB4 signaling regulates Kv4.2-mediated transient outward K+ current through the Akt/mTOR pathway, American Journal of Physiology-Cell Physiology, 305, 2, (C197), (2013).
- Saurav Seshadri, Mariela Zeledon and Akira Sawa, Synapse-specific contributions in the cortical pathology of schizophrenia, Neurobiology of Disease, 10.1016/j.nbd.2013.01.009, 53, (26-35), (2013).
- M Mizuno, H Sotoyama, H Namba, M Shibuya, T Eda, R Wang, T Okubo, K Nagata, Y Iwakura and H Nawa, ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions, Translational Psychiatry, 3, 4, (e252), (2013).
- Kim B. Seroogy, Jonathan W. Dickerson, Sarah N. Cassella and Lixin Zhang-Auberson, Neuregulins, Handbook of Biologically Active Peptides, 10.1016/B978-0-12-385095-9.00223-2, (1633-1638), (2013).
- R.-S. Woo, J.-H. Lee, H.-S. Kim, C.-H. Baek, D.-Y. Song, Y.-H. Suh and T.-K. Baik, Neuregulin-1 protects against neurotoxicities induced by Swedish amyloid precursor protein via the ErbB4 receptor, Neuroscience, 202, (413), (2012).
- Candan Depboylu, Matthias Höllerhage, Stefan Schnurrbusch, Patrik Brundin, Wolfgang H. Oertel, André Schrattenholz and Günter U. Höglinger, Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson disease, Neuroscience Letters, 531, 2, (209), (2012).
- Thomas Carlsson, Friederike R. Schindler, Matthias Höllerhage, Candan Depboylu, Oscar Arias‐Carrión, Stefan Schnurrbusch, Thomas W. Rösler, Wojciech Wozny, Gerhard P. Schwall, Karlfried Groebe, Wolfgang H. Oertel, Patrik Brundin, André Schrattenholz and Günter U. Höglinger, Systemic administration of neuregulin‐1β1 protects dopaminergic neurons in a mouse model of Parkinson’s disease, Journal of Neurochemistry, 117, 6, (1066-1074), (2011).
- Ran-Sook Woo, Ji-Hye Lee, Ha-Nul Yu, Dae-Yong Song and Tai-Kyoung Baik, Expression of ErbB4 in the neurons of Alzheimer's disease brain and APP/PS1 mice, a model of Alzheimer's disease, Anatomy & Cell Biology, 44, 2, (116), (2011).
- Jifei Zhang, Fusheng Zhao, Geng Wu, Yuezhen Li and Xiudong Jin, Functional and Histological Improvement of the Injured Spinal Cord Following Transplantation of Schwann Cells Transfected With NRG1 Gene, The Anatomical Record, 293, 11, (1933-1946), (2010).
- Ran-Sook Woo, Ji-Hye Lee, Ha-Nul Yu, Dae-Yong Song and Tai-Kyoung Baik, Expression of ErbB4 in the apoptotic neurons of Alzheimer's disease brain, Anatomy & Cell Biology, 43, 4, (332), (2010).
- Ariane Sharif and Vincent Prevot, ErbB receptor signaling in astrocytes: A mediator of neuron-glia communication in the mature central nervous system, Neurochemistry International, 10.1016/j.neuint.2010.05.012, 57, 4, (344-358), (2010).
- Jennifer F. Iaci, Anindita Ganguly, Seth P. Finklestein, Tom J. Parry, JingMei Ren, Subhash Saha, Dana K. Sietsma, Maya Srinivas, Andrea M. Vecchione and Anthony O. Caggiano, Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke, Neuropharmacology, 59, 7-8, (640), (2010).
- J.W. Dickerson, A.M. Hemmerle, S. Numan, K.H. Lundgren and K.B. Seroogy, Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats, Neuroscience, 10.1016/j.neuroscience.2009.06.008, 163, 1, (482-489), (2009).
- Y. Abe, H. Namba, Y. Zheng and H. Nawa, In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: Implication of ErbB receptors for dopaminergic neurons, Neuroscience, 10.1016/j.neuroscience.2009.03.022, 161, 1, (95-110), (2009).
- Yingjun Zheng, Akiya Watakabe, Masahiko Takada, Akiyoshi Kakita, Hisaaki Namba, Hitoshi Takahashi, Tetsuo Yamamori and Hiroyuki Nawa, Expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33, 4, (701), (2009).
- Hong-Xing Zhang, Jing-Ping Zhao, Lu-Xian Lv, Wen-Qiang Li, Lin Xu, Xuan Ouyang, Zhi-Qing Yuan and Jin-Song Huang, Explorative study on the expression of neuregulin-1 gene in peripheral blood of schizophrenia, Neuroscience Letters, 438, 1, (1), (2008).
- Lin Mei and Wen-Cheng Xiong, Neuregulin 1 in neural development, synaptic plasticity and schizophrenia, Nature Reviews Neuroscience, 10.1038/nrn2392, 9, 6, (437-452), (2008).
- Don M. Gash, Yan Chen and Greg Gerhardt, Neurotrophic factors and Parkinson's disease, Parkinson's Disease and Related Disorders, Part I, 10.1016/S0072-9752(07)83025-9, (521-533), (2007).
- Hans O. Kalkman, The role of the phosphatidylinositide 3-kinase–protein kinase B pathway in schizophrenia, Pharmacology & Therapeutics, 110, 1, (117), (2006).
- KIM B. SEROOGY and LIXIN ZHANG, Neuregulins, Handbook of Biologically Active Peptides, 10.1016/B978-012369442-3/50198-7, (1401-1406), (2006).
- David M. Yurek, Lixin Zhang, Anita Fletcher-Turner and Kim B. Seroogy, Supranigral injection of neuregulin1-β induces striatal dopamine overflow, Brain Research, 1028, 1, (116), (2004).
- Sudheendra N. R. Rao and Damien D. Pearse, Regulating Axonal Responses to Injury: The Intersection between Signaling Pathways Involved in Axon Myelination and The Inhibition of Axon Regeneration, Frontiers in Molecular Neuroscience, 10.3389/fnmol.2016.00033, 9, (2016).
- Taisuke Kato, Atsushi Kasai, Makoto Mizuno, Liang Fengyi, Norihito Shintani, Sadaaki Maeda, Minesuke Yokoyama, Miwako Ozaki, Hiroyuki Nawa and Thomas Burne, Phenotypic Characterization of Transgenic Mice Overexpressing Neuregulin-1, PLoS ONE, 10.1371/journal.pone.0014185, 5, 12, (e14185), (2010).
